GAP43 and Alzheimer disease: For example, the GHABS research group has investigated the characteristics of CSF GAP43 in different clinical and pathological stages of AD [11] based on the ADNI cohort and demonstrated that presynaptic dysfunction measured by CSF GAP43 occurs prior to AD typical neurodegeneration and predicts faster cognitive decline [12].